Al-Dossary, A.A.; Tawfik, E.A.; Isichei, A.C.; Sun, X.; Li, J.; Alshehri, A.A.; Alomari, M.; Almughem, F.A.; Aldossary, A.M.; Sabit, H.;
et al. Engineered EV-Mimetic Nanoparticles as Therapeutic Delivery Vehicles for High-Grade Serous Ovarian Cancer. Cancers 2021, 13, 3075.
https://doi.org/10.3390/cancers13123075
AMA Style
Al-Dossary AA, Tawfik EA, Isichei AC, Sun X, Li J, Alshehri AA, Alomari M, Almughem FA, Aldossary AM, Sabit H,
et al. Engineered EV-Mimetic Nanoparticles as Therapeutic Delivery Vehicles for High-Grade Serous Ovarian Cancer. Cancers. 2021; 13(12):3075.
https://doi.org/10.3390/cancers13123075
Chicago/Turabian Style
Al-Dossary, Amal A., Essam A. Tawfik, Adaugo C. Isichei, Xin Sun, Jiahe Li, Abdullah A. Alshehri, Munther Alomari, Fahad A. Almughem, Ahmad M. Aldossary, Hussein Sabit,
and et al. 2021. "Engineered EV-Mimetic Nanoparticles as Therapeutic Delivery Vehicles for High-Grade Serous Ovarian Cancer" Cancers 13, no. 12: 3075.
https://doi.org/10.3390/cancers13123075
APA Style
Al-Dossary, A. A., Tawfik, E. A., Isichei, A. C., Sun, X., Li, J., Alshehri, A. A., Alomari, M., Almughem, F. A., Aldossary, A. M., Sabit, H., & Almalik, A. M.
(2021). Engineered EV-Mimetic Nanoparticles as Therapeutic Delivery Vehicles for High-Grade Serous Ovarian Cancer. Cancers, 13(12), 3075.
https://doi.org/10.3390/cancers13123075